Consistent adherence to guidelines improves opioid dependent patients' first year outcomes

Journal of Behavioral Health Services and Research

Volumn 34, Issue 3, 2007, Pages 260-271

  Trafton, Jodie A ^a,b   Humphreys, Keith ^a,b   Harris, Alex H S ^a   Oliva, Elizabeth ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Clinical practice guidelines; Effectiveness; Heroin; Methadone maintenance; Quasi experimental design

Indexed keywords

METHADONE;

ADULT; ARTICLE; CLINICAL PRACTICE; COCAINE DEPENDENCE; FEMALE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CARE; METHADONE TREATMENT; OPIATE ADDICTION; PATIENT CARE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PSYCHOSOCIAL CARE;

ADULT; CLINICAL PROTOCOLS; FEMALE; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); SUBSTANCE ABUSE TREATMENT CENTERS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 34548183377     PISSN: 10943412     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11414-007-9074-2     Document Type: Article

References (37)

1. Newman RG, Whitehill WB. Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts. The Lancet. 1979;8141:485-488.
2. Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction. 1998;93(4):515-532.
3. Mattick RP, Breen C, Kimber J, et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews. 2003;(2):CD002209.
4. Krantz MJ, Mehler PS. Treating opioid dependence. Growing implications for primary care. Archives of Internal Medicine. 2004;164(3):277-288.
5. Ling W, Charuvastra C, Kaim SC, et al. Methadyl acetate and methadone as maintenance treatments for heroin addicts. A Veterans Administration cooperative study. Archives of General Psychiatry. 1976;33:709-720.
6. Faggiano F, Vigna-Taglianti F, Versino E, et al. Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews. 2003;3:CD002208.
7. Strain EC, Bigelow GE, Liebson IA, et al. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. Journal of the American Medical Association. 1999;281(11):1000-1005.
8. Strain EC, Stitzer ML, Liebson IA, et al. Dose-response effects of methadone in the treatment of opioid dependence. Annals of Internal Medicine. 1993;119(1):23-27.
9. Maxwell S, Shinderman MS. Optimizing long-term response to methadone maintenance treatment: a 152-week follow-up using higher-dose methadone. Journal of Addictive Disease. 2002;21(3):1-12.
10. Amato L, Minozzi S, Davoli M, et al. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Systematic Reviews 2004;(4):CD004147.
11. McLellan AT, Arndt IO, Metzger DS, et al. The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association. 1993;269:1953-1959.
12. Department of Veterans Affairs/Department of Defense. Clinical practice guideline for the management of substance use disorders. Available at: http://www.oqp.med.va.gov/cpg, Accessed August 8, 2006.
13. Parrino M. Consensus Panel Chair. State Methadone Treatment Guidelines. TIP Series 1. DHHS Publication No. (SMA) 93-1991. Rockville, Maryland: DHHS; 1993.
14. National Institutes of Health-Center for Disease Control. Effective treatment of heroin addiction. NIH Consensus Statement. Bethesda, MD: National Institutes of Health; 1997.
15. American Psychiatric Association. Position statement on methadone maintenance. American Journal of Psychiatry. 1994;151:792-794.
16. Kreek MJ. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Annals of the New York Academy of Sciences. 2000;909:186-216.
17. Woody GE. Research findings on psychotherapy of addictive disorders. The American Journal on Addictions. 2003;12:S19-S26.
18. D'Aunno T, Pollack HA. Changes in methadone treatment practices: results from a national panel study, 1988-2000. Journal of the American Medical Association. 2002;288(7):850-856.
19. D'Aunno T, Vaughn TE. Variations in methadone treatment practices: Results from a national study. Journal of the American Medical Association. 1992;267:253-258.
20. Hamilton EG, Humphreys K. Outpatient methadone services in the Department of Veterans Affairs. Palo Alto, CA: Program Evaluation & Resource Center; 1996.
21. Trafton JA, Humphreys KN, Kivlahan D, et al. Barriers to implementation of an evidence-based practice: the example of methadone maintenance. Journal of Addictive Diseases. 2005;24(S1):93-108.
22. Bell J. Quality improvement for methadone maintenance treatment. Substance Use and Misuse. 2000;35(12-14):1735-1736.
23. Hobden KL, Cunningham JA. Barriers to the dissemination of four harm reduction strategies: a survey of addiction treatment providers in Ontario. Harm Reduction Journal. 2006;3:35.
24. Appel PW, Ellison AA, Jansky HK, et al. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders. American Journal of Drug and Alcohol Abuse. 2004;30(1):129-153.
25. Zule WA, Desmond DP. Attitudes toward methadone maintenance: implications for HIV prevention. Journal of Psychoactive Drugs. 1998;30(1):89-97.
26. McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the addiction severity index. Journal of Substance Abuse Treatment. 1992;9:1999-2013.
27. Kazis LE, Ren XS, Lee A, et al. Health status in VA patients: results from the Veterans Health Study. American Journal of Medical Quality. 1999;14:28-38.
28. NOVA Research Company. Program Orientation Book for NIDA National AIDS Demonstration Research (NADR) Grantees and AIDS Targeted Outreach Program (ATOM), Bethesda, MD: National Institute on Drug Abuse; 1989.
29. Fureman B, Parikh G, Bragg A, et al. Addiction severity index fifth edition: a guide to training and supervising ASI interviews based on the past ten years. Philadelphia, PA: VA Center for Studies of Addiction; 1990.
30. Ware JE Jr, Snow KK, Kosinski M, et al. SF-36 Health Survey Manual & Interpretation Guide. Boston: Nimrod Press, 1993.
31. Trafton JA, Minkel J, Humphreys K. Determining effective methadone doses for individual opioid dependent patients. Public Library of Science Medicine. 2006;3(3):e80.
32. Goldstein A, Brown BW. Urine testing in methadone maintenance treatment: applications and limitations. Journal of Substance Abuse Treatment. 2003;25(2):61-63.
33. McLellan AT. Patient characteristics associated with outcome. In: JR Cooper, Altman, BS, Brown, et al. Research on the treatment of narcotic addiction: State of the art. Rockville, MD: National Institute on Drug Abuse, 1983.
34. Sees KL, Delucchi KL, Masson C, et al. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. Journal of the American Medical Association. 2000;283(10):1303-1310.
35. Office of National Drug Control Policy. (2000). Pulse check trends in drug abuse mid-year 2000. Available at: http://www.whitehousedrugpolicy.gov/ publications/drugfact/pulsechk/midyear2000/heroin.html Accessed August 8, 2006.
36. Willenbring ML, Hagedorn HJ, Postier AC, et al. Variations in evidence-based clinical practices in nine United States Veterans Administration opioid agonist therapy clinics. Drug and Alcohol Dependence. 2004;75:91-106.
37. Donny EC, Walsh SL, Bigelow GE, et al. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Psychopharmacology. 2002;161(2):202-212.